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Hepatitis E Virus 
Mixed Infection in 
Immunocompetent 
Patient
Donald B. Smith, Jeff Vanek, Louise Wellington, 
Ingolfur Johannessen, Sandeep Ramalingam, 
and Peter Simmonds
We detected 2 hepatitis E virus (HEV) strains in an 
acutely infected immunocompetent patient. Two populations 
of	genotype	3	virus	were	observed	in	the	hypervariable	re-
gions	and,	open	reading	frames	2	and	3,	indicating	multiple	
infection	with	 hepatitis	E	 virus.	Persons	with	mixed	 infec-
tions may provide the opportunity for virus recombination.
Most reports of multiple infection with different hepa-titis E virus (HEV) variants can be ascribed to immu-
nodeficiency of the host or to high frequencies of infection. 
For example, 2 different genotype 3 subtypes were detected 
in samples from an immunocompromised kidney transplant 
recipient (1), and virus from another immunocompromised 
patient contained an insertion of host-derived sequences 
or various deletions of this sequence (2). Multiple infec-
tion or co-circulation of closely related virus variants is 
not unexpected in such patients with chronic HEV infec-
tion (references in [3]). Few cases of multiple infection of 
immunocompetent persons have been reported; 2 different 
virus genotypes were isolated from a sushi chef in Japan 
(4), and 2 persons in Nepal were each infected by different 
genotype 1 subtypes (5). In the course of our study of the 
open reading frame (ORF) 1 hypervariable region (HVR) 
variability in acutely infected persons in Scotland (6), we 
described a person infected with 2 variants of HEV that 
encoded dramatically distinct HVR sequences. We report 
here a more complete investigation of this case.
The Study
The patient, a 55-year-old man, sought treatment 
at a hospital in the southeast of Scotland in April 2012 
for nausea, vomiting, anorexia, jaundice, headache, and 
abdominal pain. At admission, the patient’s blood sam-
ple was positive for anti-HEV IgM and IgG and raised 
levels of alanine aminotransferase (ALT) (4,023 IU/L; 
reference range 5–60 IU/L) and bilirubin (91 μmol/L; 
reference range 3–17 μmol/L). Over the next 10 days, 
ALT declined steadily to 404 IU/L and returned to normal 
levels 1 month later. The patient’s abdominal pain had 
largely resolved by 6 weeks after seeking treatment, but 
fatigue and lethargy persisted for >8 weeks. There was 
no evidence that the patient was immunocompromised or 
was co-infected with other hepatitis viruses. The patient 
had unexplained jaundice at age 10 years and a history 
of alcohol abuse as an adult. Symptoms were relatively 
severe and required 6 days of hospitalization. Informed 
consent was provided by the patient for laboratory assess-
ment of blood samples.
Virus RNA was extracted from 140 μL of serum and 
sequenced at limiting dilution in the HVR and ORF2 re-
gions as described (6). Analysis of the ORF2/ORF3 overlap 
region used the primers 5′-CGGGTGGAATGAATAA-
CATGT-3′ (outer sense nucleotides 5098–5118 relative to 
M73218), 5′-GCRGTYARCGGCGMRGCCCCAGCTG-3′ 
(outer antisense, 5481–5457), 5′-TYTGCCTATGCTGCCC-
GCGCCACCG-3′ (inner sense, 5184–5209) and 5′-GGC-
GCTGGGMYTGGTCRCGCCAAG-3′ (inner antisense, 
5426–5403). Negative controls were included in all ex-
periments. GenBank accession numbers for the ORF2 and 
ORF2/3 sequences described here are JX516004–JX516053 
and for the HVR sequences are JX270882–JX270902.
Nucleotide sequence analysis of the HVR from indi-
vidual virus genomes sampled by limiting dilution of cDNA 
revealed 2 distinct genotype 3 populations (populations A 
and B, Figure). Members of these populations all differed 
by the same 18 nucleotide substitutions, of which 13 were 
synonymous and 5 nonsynonymous. Two populations (A 
and B) were also observed among 25 ORF2 sequences (the 
2 populations differed by 5 synonymous substitutions) and 
26 ORF2/ORF3 sequences (the 2 populations differed by 
a single substitution, which was nonsynonymous in ORF2 
but synonymous in ORF3). 
In all 3 regions, 1 of the virus populations represented 
≈80%–90% of the sequences: in HVR, 17 sequences were 
population A and 4 population B; in ORF2, 21 sequences 
were population A, 2 population B, and 1 mixed; and in 
ORF2/3, 20 sequences were population A, 4 population 
B, and 2 mixed. The 3 mixed sequences contained ambi-
guities at positions where the 2 populations differed, im-
plying that templates from both populations were present 
in the limiting dilution reaction. The expected number of 
such mixed-template reactions can be calculated by using 
the Poisson distribution and the number of PCR-negative 
replicate reactions, which were 47% (HVR), 50% (ORF2), 
and 43% (ORF2/3). Thus, 17.5%, 15.4%, and 20.8%, re-
spectively, of reactions would be expected to contain >1 
template, of which, given the ratio of populations A and B 
in each region, 31%, 17.2%, and 28%, respectively, would 
contain templates from different populations, equivalent 
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to 5.4%, 2.6%, and 5.8%, respectively, of positive reac-
tions, compared with the 4.2% (3/71) observed. All oth-
er substitutions in these sequence sets were unique to a 
single sequence. A trivial explanation for the observation 
of mixed populations in this sample would be contami-
nation during sample collection, processing, or analysis. 
However, this appears unlikely, given the low frequen-
cy of HEV infection in the United Kingdom, the lack of 
PCR products in negative controls, and the distinctness of 
the sequences obtained from those previously studied in 
our laboratory.
Infection of the patient in this study with 2 HEV vari-
ants could arise for several different reasons. First, the per-
son could have been exposed to a homogeneous source of 
HEV, which then diversified during infection. Assuming 
that infection occurred 1 month before the first symptoms 
and 6 weeks before sampling, a divergence of HVR se-
quences at 18 (7.4%) of 243 nucleotide positions equates to 
a rate of nucleotide substitution from a presumed ancestor 
of both populations of 0.32/site/year. Not only were these 
substitutions mostly synonymous, and therefore unlikely 
to represent selection during infection, but the inferred 
rate of nucleotide substitution would be several orders of 
magnitude higher than those previously reported for HEV 
(0.0014/site/year) (7) or for the HCV HVR (0.0043/site/
year) (8). In addition, the divergence between the 2 vi-
rus populations contrasts with the homogeneity observed 
among 7 other acutely infected patients and between vi-
ruses transmitted from 1 person or host to another (6).
A second possibility is that this person had a subclini-
cal chronic HEV infection and then became superinfected 
with a second virus that induced jaundice. No previous 
blood samples were available for testing, but a prior sub-
clinical chronic infection seems unlikely, given the absence 
of immunosuppression; the presence of anti-HEV IgM and 
IgG; the decline and increase, respectively, in these anti-
body titers in a sample collected 7 days later; and the de-
cline in ALT and bilirubin levels in the weeks following the 
patient’s hospital visit.
Last, the clinical features and our immunologic and vi-
rologic findings are consistent with the patient having been 
infected from a single source containing >1 variant, such as 
pig-derived figatellu sausage (9). Alternatively, he might 
have been multiply infected from different sources within 
in a short period and before the development of protective 
immunity. Follow-up interview revealed no occupational 
exposure to animals, apart from a domestic dog, and no 
recent foreign travel; he spent 3 days in a beach resort in 
southeastern Scotland 12 days before onset of symptoms. 
The patient ate supermarket-bought prewashed salad veg-
etables and fresh fruit and drank only bottled or tap water. 
The patient ate fish, shellfish, chicken, pork, bacon, sausag-
es, ham, Brussels paté, and eggs but not venison or pig liv-
er. He regularly handled uncooked pork and beef at home 
while preparing food. HEV has been found on the hands 
and gloves of 17% of persons selling pork products (10).
Conclusions
This study suggests that mixed infection with HEV can 
occur in immunocompetent persons with no obvious high-
risk exposure to HEV-infected food or sewage. Only about 
300 cases of acute HEV are reported each year in England 
and Wales (11), and the prevalence of HEV PCR-positive 
blood donors in England is 0.014% (12). However, the 
Figure. Phylogenetic tree of hepatitis E virus hypervariable region 
variants. A neighbor-joining tree of hypervariable region sequences 
was constructed by using MEGA 4 (15). A and B indicate sequences 
for virus populations A and B. Sequences from the patient studied 
here (patient 21) belonging to virus population A are indicated 
by a solid square, and those belonging to virus population B 
are	 indicated	 by	 a	 solid	 circle.	Other	 sequences	 obtained	 in	 the	
same laboratory are indicated by an open circle. Closely related 
genotype	 3	 sequences	 obtained	 from	GenBank	 are	 identified	 by	
their accession number. Bootstrap support (1,000 replicates) for 
branches	 of	 >70%	 are	 indicated.	 Scale	 bar	 indicates	 nucleotide	
substitutions per site.
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seroprevalence of anti-HEV IgG is 1,000× higher (16%) 
(13), and in this context, the identification of sources of 
autochthonous HEV infection remains an important goal. 
Our results are also relevant to the suggestion that HEV 
may undergo recombination (14). The case described here 
suggests that the conditions required for virus recombina-
tion may occasionally arise in immunocompetent persons.
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